FRINGEHE

Uncovering the Role of Notch Modifiers in the Generation of Hematopoietic Stem Cells in the Embryo

 Coordinatore FUNDACIO IMIM 

 Organization address address: Doctor Aiguader 88
city: BARCELONA
postcode: 8003

contact info
Titolo: Mr.
Nome: Andreu
Cognome: Fort
Email: send email
Telefono: +34 933161690

 Nazionalità Coordinatore Spain [ES]
 Totale costo 168˙896 €
 EC contributo 168˙896 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IEF
 Funding Scheme MC-IEF
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-05-01   -   2014-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    FUNDACIO IMIM

 Organization address address: Doctor Aiguader 88
city: BARCELONA
postcode: 8003

contact info
Titolo: Mr.
Nome: Andreu
Cognome: Fort
Email: send email
Telefono: +34 933161690

ES (BARCELONA) coordinator 168˙896.40

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

arterial    crucial    knock    molecular    signalling    cell    therapies    ligands    hsc    endothelium    fringe    emergence    issue    hematopoietic    embryos    stem    notch    cells    hscs    cellular    vitro   

 Obiettivo del progetto (Objective)

'Hematopoietic Stem Cell (HSC)-based therapies are becoming a great expectation for the cure of several disorders that require HSCs for treatment. However, the incapacity to generate and maintain fully potent transplantable HSCs in vitro is still nowadays one of the main limitations for their wide application in cellular therapies. The study of the molecular mechanisms underlying HSC ontogeny in embryos is thus of crucial importance in order to elucidate the genetic networks that control the emergence and expansion of these cells. HSCs are first and possibly entirely formed in arterial-endothelium during embryonic life, a process dependent on Notch-signalling. However, the molecular events regulating these signals are mainly unknown. Fringe-glycosyltransferases are Notch modifiers contributing to the differential response of Notch to distinct ligands. It is hypothesized that the cross-talk between Notch and its cognate ligands in the arterial endothelium compartment is primarily a consequence of Fringe-mediated modification and the driving-force towards endothelium-HSC transition. This project aims the elucidation of the role Fringe as modulators of Notch-signalling towards specification of HSC identity at mid-gestation mouse embryos, an issue that has not been addressed so far. This work will be initiated with the identification of the Fringe involved on HSC emergence and with the study on how the modulation of their expression is correlated with Notch-ligand responsiveness and formation of hematopoietic precursors in vitro. The results obtained in this part of the project will be the basis of further in vivo experiments, using Fringe knock-in and knock-out animal models. The execution of this proposal should provide relevant clues on important biological questions involving stemness and cell differentiation. Moreover, it will pave the way for the development of new and more robust strategies to produce and expand HSCs a crucial issue for regenerative medicine.'

Introduzione (Teaser)

Understanding how tissues form during development helps to extrapolate this information in the adult organism. With a focus on the production of cellular components of blood in the embryo (haematopoiesis), the FRINGEHE study unravelled key molecular determinants of haematopoietic stem cells (HSCs).

Altri progetti dello stesso programma (FP7-PEOPLE)

STAGED (2012)

"Stress and the aging brain: the interplay between genetic susceptibility, aging and psychosocial stress on early symptoms of dementia"

Read More  

CAVABLATE (2015)

Cavitation enhanced Ablation for Focused Ultrasound Surgery

Read More  

DOS (2015)

Synthesis of small molecules and evaluation of their biological activity: discovery of new protein-protein interaction inhibitors

Read More